Quick Dispatch:
Your altimmune glp 1 Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your altimmune glp 1 Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study ships.
Need Help?
Questions about altimmune glp 1 Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for altimmune glp 1 Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study in your area.
Pemvidutide Cuts NAFLD Liver Fat and Weight Through 24 Weeks
22.18
New GLP-1 Weight-Loss Drug Mimics Effects of Exercise With a Shot
26.76
ICYMI Our CEO, Dr. Vipin Garg, joined @CNBC's “Fast Money” to share Altimmune's progress, vision and future developments surrounding our lead candidate #pemvidutide, a #GLP1/#Glucagon dual receptor agonist for the treatment of #
28.49
Altimmune hits NASH target in phase 1 trial
25.64
Altimmune | Biotechnology
23.67
Altimmune Touts Pemvidutide Progress, Targets MASH Phase 3 Start and Q3 AUD Readout at Barclays Chat
27.53
Altimmune cuts hepatitis B program, reports more data on its GLP-1/glucagon for obesity and MASH
22.36
